Reaction Details |
| Report a problem with these data |
Target | Fatty-acid amide hydrolase 1 |
---|
Ligand | BDBM50342056 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_743931 (CHEMBL1767925) |
---|
Ki | 57±n/a nM |
---|
Citation | Ezzili, C; Mileni, M; McGlinchey, N; Long, JZ; Kinsey, SG; Hochstatter, DG; Stevens, RC; Lichtman, AH; Cravatt, BF; Bilsky, EJ; Boger, DL Reversible competitivea-ketoheterocycle inhibitors of fatty acid amide hydrolase containing additional conformational constraints in the acyl side chain: orally active, long-acting analgesics. J Med Chem54:2805-22 (2011) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Fatty-acid amide hydrolase 1 |
---|
Name: | Fatty-acid amide hydrolase 1 |
Synonyms: | Anandamide amidohydrolase | Anandamide amidohydrolase 1 | FAAH | FAAH1 | FAAH1_HUMAN | Fatty Acid Amide Hydrolase (FAAH) | Fatty-acid amide hydrolase (FAAH) | Fatty-acid amide hydrolase 1 | Oleamide hydrolase 1 |
Type: | Protein |
Mol. Mass.: | 63071.19 |
Organism: | Homo sapiens (Human) |
Description: | O00519 |
Residue: | 579 |
Sequence: | MVQYELWAALPGASGVALACCFVAAAVALRWSGRRTARGAVVRARQRQRAGLENMDRAAQ
RFRLQNPDLDSEALLALPLPQLVQKLHSRELAPEAVLFTYVGKAWEVNKGTNCVTSYLAD
CETQLSQAPRQGLLYGVPVSLKECFTYKGQDSTLGLSLNEGVPAECDSVVVHVLKLQGAV
PFVHTNVPQSMFSYDCSNPLFGQTVNPWKSSKSPGGSSGGEGALIGSGGSPLGLGTDIGG
SIRFPSSFCGICGLKPTGNRLSKSGLKGCVYGQEAVRLSVGPMARDVESLALCLRALLCE
DMFRLDPTVPPLPFREEVYTSSQPLRVGYYETDNYTMPSPAMRRAVLETKQSLEAAGHTL
VPFLPSNIPHALETLSTGGLFSDGGHTFLQNFKGDFVDPCLGDLVSILKLPQWLKGLLAF
LVKPLLPRLSAFLSNMKSRSAGKLWELQHEIEVYRKTVIAQWRALDLDVVLTPMLAPALD
LNAPGRATGAVSYTMLYNCLDFPAGVVPVTTVTAEDEAQMEHYRGYFGDIWDKMLQKGMK
KSVGLPVAVQCVALPWQEELCLRFMREVERLMTPEKQSS
|
|
|
BDBM50342056 |
---|
n/a |
---|
Name | BDBM50342056 |
Synonyms: | (S)-oxazol-2-yl(6-phenyl-1,2,3,4-tetrahydronaphthalen-2-yl)methanone | CHEMBL1765822 |
Type | Small organic molecule |
Emp. Form. | C20H17NO2 |
Mol. Mass. | 303.3545 |
SMILES | O=C([C@H]1CCc2cc(ccc2C1)-c1ccccc1)c1ncco1 |r| |
Structure |
|